Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: New England Journal of Medicine
Authors: Kuniaki Takahashi, Ken Kozuma, Yoshihiro Morino, Kosuke Kashiwabara, Hiromasa Otake, Satoru Suwa, Mamoru Nanasato, Takashi Muramatsu, Hitoshi Anzai, Akihiro Shirakabe, Masashi Yamamoto, Yasuhide Asaumi, Masashi Sakuma, Hideki Okayama, Keisuke Nakabayashi, Nobuhiko Ogata, Kentaro Jujo, Kohei Wakabayashi, Takanori Kusuyama, Yuko Onishi, Kazuhiro Ashida, Yuya Mitsuhashi, Yuji Nishimoto, Seiji Yamazaki, Nehiro Kuriyama, Yuji Ikari, Gaku Nakazawa
Institutions: Kindai University, Teikyo University, Iwate Medical University Hospital, University of Tokyo Hospital, Kobe University, Juntendo University, Juntendo University Shizuoka Hospital, Fujita Health University Hospital, Fuji Heavy Industries Health Insurance Society Ota Memorial Hospital, Chiba Hokusou Hospital, Nippon Medical School, Kimitsu Chuo Hospital, National Cerebral and Cardiovascular Center, Dokkyo Medical University Hospital, Ehime Prefectural Central Hospital, Dokkyo Medical University Saitama Medical Center, Ageo Central General Hospital, Saitama Medical Center, Saitama Medical University, Saitama Medical University, SHOWA Medical University Koto Toyosu Hospital, Tsukazaki Hospital, Hiratsuka Kyosai Hospital, Seirei Yokohama Hospital, Tokyo Metropolitan Tama Medical Center, Osaka Prefectural Medical Center, Toyonaka Municipal Hospital, Sapporo Higashi Tokushukai Hospital, Miyazaki Medical Association Hospital, Tokai University Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Boston Scientific Japan
OpenAlex ID: W7204638577